-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
MESOS: considerations in designing a mechanistic study for a biologic used to treat asthma
Christopher Brightling, Millie Wang, Martin Braddock, Lars Nordenmark, Mattis Gottlow & Gene Colice
Clinical Trail Perspective: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials
Nishith Singh, Ravi Madan, James L Gulley
Review: Clinical Trail Outcomes: Clinical Investigation